Combination Radioimmunotherapy Using 125I-MAb 425, Concomitant and Adjuvant Temozolomide (TMZ), and Radiotherapy (RT) in the Treatment of Astrocytoma with Anaplastic Foci (AAF) and Glioblastoma Multiforme (GBM): Overall Results and Recursive Partitioning Analysis (RPA) of a Phase II Pilot Study and Historical Institutional Data

Journal article

Open access

L. Li, T.S. Quang, J. Emrich and L.W. Brady

International journal of radiation oncology, biology, physics, v 63, pp S70-S70

2005

Files and links (1)

url

https://doi.org/10.1016/j.ijrobp.2005.07.121View

Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze), Open

9 Record Views

Title: Combination Radioimmunotherapy Using 125I-MAb 425, Concomitant and Adjuvant Temozolomide (TMZ), and Radiotherapy (RT) in the Treatment of Astrocytoma with Anaplastic Foci (AAF) and Glioblastoma Multiforme (GBM): Overall Results and Recursive Partitioning Analysis (RPA) of a Phase II Pilot Study and Historical Institutional Data
Creators: L. Li - Department of Radiation Oncology Drexel University College of Medicine Philadelphia PA
T.S. Quang - University of California, Davis
J. Emrich - Drexel University
L.W. Brady - Drexel University
Publication Details: International journal of radiation oncology, biology, physics, v 63, pp S70-S70
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Radiation Oncology (and Nuclear Medicine); [Retired Faculty]
Web of Science ID: WOS:000232083300118
Other Identifier: 991019169110004721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration
Web of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging